Grail (GRAL) Non-Current Assets (2023 - 2026)
Grail's (GRAL) quarterly Non-Current Assets came in at $1.9 billion in Q2 2026, down 5.94% on a YoY basis from $2.1 billion in Q2 2025, and little changed quarter-over-quarter from $1.9 billion in Q1 2026.
Analysis
Grail (GRAL) Non-Current Assets (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Non-Current Assets for 4 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Assets fell 5.94% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $7.8 billion (down 8.28% YoY), and the FY2025 full-year result was $2.0 billion, down 9.03% from the prior year.
- Non-Current Assets was little changed at $1.9 billion in Q2 2026 per GRAL's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $3.8 billion in Q4 2023 and bottomed at $1.9 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $2.2 billion across 4 years, with a median of $2.1 billion in 2025.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets sank 42.43% in 2024, then fell 5.94% in 2026.
- Over 4 years, Non-Current Assets stood at $3.8 billion in 2023, then tumbled by 42.43% to $2.2 billion in 2024, then slipped by 9.03% to $2.0 billion in 2025, then retreated by 1.99% to $1.9 billion in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.9 billion, $1.9 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 998.55 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 14.10 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 14.72 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 547.66 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 14.60 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 171.79 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 2.66 Bn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 78.32 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 220.12 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 1.93 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.93 Bn |
| Mar 31, 2026 | 1.93 Bn |
| Dec 31, 2025 | 1.97 Bn |
| Sep 30, 2025 | 2.01 Bn |
| Jun 30, 2025 | 2.05 Bn |
| Mar 31, 2025 | 2.12 Bn |
| Dec 31, 2024 | 2.16 Bn |
| Sep 30, 2024 | 2.21 Bn |
| Jun 30, 2024 | 2.25 Bn |
| Dec 31, 2023 | 3.76 Bn |